Eisai
|
4,030.00 |
|
-24.00 |
-0.59% |
-36.78% |
2025-06-16 |
ALKERMES
|
29.65 |
|
-0.18 |
-0.60% |
21.02% |
2025-06-16 |
Alnylam Pharmaceuticals
|
308.98 |
|
0.99 |
0.32% |
96.43% |
2025-06-16 |
Amarin
|
13.27 |
|
0.02 |
0.11% |
1,604.79% |
2025-06-16 |
ANI Pharmaceuticals
|
64.15 |
|
1.59 |
2.54% |
3.84% |
2025-06-16 |
Arrowhead Research
|
15.61 |
|
-0.13 |
-0.83% |
-37.81% |
2025-06-16 |
GlaxoSmithKline
|
1,485.50 |
|
-26.00 |
-1.72% |
-7.16% |
2025-06-16 |
Insmed
|
100.42 |
|
1.69 |
1.71% |
55.21% |
2025-06-16 |
Ligand Pharmaceuticals
|
114.32 |
|
1.82 |
1.62% |
41.77% |
2025-06-16 |
Merck
|
80.83 |
|
-0.85 |
-1.04% |
-36.66% |
2025-06-16 |
Neurocrine Biosciences
|
125.56 |
|
1.17 |
0.94% |
-7.19% |
2025-06-16 |
Pacira
|
24.18 |
|
-0.06 |
-0.25% |
-11.56% |
2025-06-16 |
Ultragenyx Pharmaceutical
|
37.30 |
|
-0.19 |
-0.51% |
-6.28% |
2025-06-16 |
Regeneron Pharmaceuticals
|
526.58 |
|
-2.07 |
-0.39% |
-49.64% |
2025-06-16 |
Roche Holding
|
262.90 |
|
-6.80 |
-2.52% |
7.09% |
2025-06-16 |
Veracyte
|
26.56 |
|
0.12 |
0.45% |
24.23% |
2025-06-16 |
Vertex Pharmaceuticals
|
451.63 |
|
-8.04 |
-1.75% |
-6.06% |
2025-06-16 |